Table 1.
Regression analysis results comparing the frequency and rates of variant types per-individual genome across 10 global populations.
| Y-int | Africa |
Europe |
Asia |
India | Mexico | R-Sqr | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LW | AS | MK | CE | TS | CH | JP | GI | ME | |||
| Total derived genotypes | 6042271.00 | −83419.25 | −57488.00 | −51149.25 | −395516.33 | −375283.25 | −428364.00 | −442378.00 | −332701.50 | −444921.80 | 0.97 |
| Non-sense SNPs: | 117.11 | 7.14 | 3.09 | −4.86 | −12.44 | −11.61 | −10.36 | −12.11 | −12.61 | −5.11 | 0.45 |
| Frameshift structural variants: | 450.11 | −7.86 | −3.51 | −15.36 | −64.56 | −36.11 | −35.36 | −37.61 | −21.36 | −55.11 | 0.71 |
| Splicing change variants: | 3009.33 | −17.08 | 17.47 | 9.42 | 4.33 | 14.92 | −34.08 | −48.58 | −5.08 | 2.07 | 0.29 |
| Probably damaging nscSNPs: | 2842.67 | 15.83 | 9.13 | −42.92 | −197.89 | −168.92 | −198.67 | −213.17 | −177.42 | −208.67 | 0.90 |
| Possibly damaging nscSNPs: | 2201.44 | 17.31 | 11.56 | −13.19 | −148.00 | −120.94 | −150.19 | −139.69 | −143.19 | −133.84 | 0.82 |
| Protein motif damaging variants: | 1012.22 | −16.72 | −21.02 | −17.72 | −111.44 | −82.22 | −89.47 | −109.72 | −69.47 | −108.22 | 0.76 |
| TFBS disrupting variants: | 625.67 | −92.67 | −65.67 | −39.42 | −122.56 | −117.67 | −74.17 | −80.67 | −56.42 | −155.67 | 0.75 |
| miRNA-BS disrupting variants: | 215.78 | −7.28 | −10.78 | −15.78 | −51.00 | −42.53 | −49.78 | −51.78 | −41.03 | −66.58 | 0.91 |
| ESE-BS disrupting variants: | 2912.00 | −33.25 | −6.80 | −35.75 | −141.89 | −138.50 | −187.75 | −163.25 | −134.25 | −140.00 | 0.82 |
| ESS-BS disrupting variants: | 1225.56 | −17.31 | −1.36 | 15.19 | −43.56 | −40.31 | −54.06 | −71.56 | −40.31 | −84.56 | 0.72 |
| Total likely functional variants: | 12983.11 | −148.11 | −71.31 | −133.11 | −730.11 | −599.61 | −729.61 | −734.86 | −557.86 | −783.11 | 0.90 |
| Functional variants/total variants × 100000 | 214.87 | 0.53 | 0.86 | −0.38 | 2.12 | 3.65 | 3.40 | 3.86 | 2.75 | 3.09 | 0.57 |
| Total number of novel variants: | 230608.44 | 19681.56 | −16356.84 | −26810.44 | −133947.00 | −122674.44 | −110435.44 | −113591.94 | −98801.19 | −125688.44 | 0.92 |
| Total likely functional novel variants: | 798.78 | 66.22 | −22.18 | −125.03 | −360.56 | −290.78 | −251.03 | −263.78 | −250.03 | −331.78 | 0.84 |
| Total number of homozygous genotypes: | 2919451.44 | 2748.06 | 680.16 | 30050.56 | 371821.44 | 362882.06 | 429429.81 | 426953.06 | 331099.31 | 377807.36 | 0.99 |
| Probably damaging hmz nscSNPs: | 985.00 | 0.75 | −20.80 | 25.75 | 202.78 | 191.00 | 243.75 | 191.75 | 160.00 | 207.60 | 0.97 |
| Prob Dam hmz nscSNPs/Total Var iants × 100000 | 16.30 | 0.24 | −0.19 | 0.57 | 4.73 | 4.45 | 5.58 | 4.71 | 3.75 | 5.00 | 0.98 |
| Total likely functional homozygous variants: | 6103.11 | 30.39 | −19.71 | 62.14 | 772.00 | 762.39 | 907.39 | 877.89 | 606.14 | 835.09 | 0.98 |
| Likely functional hmz variants/total Variants × 100000 | 101.02 | 1.91 | 0.64 | 1.89 | 20.74 | 20.14 | 23.86 | 23.65 | 16.49 | 22.94 | 0.99 |
Note that the YR (Yoruban) sample was taken as the reference. Y-int = Y-intercept; R-Sqr = Fraction of Variation in the Variant type explained by the regression model. Bolded entries = p-value < 0.05; Italicized entries = p-value < 0.0005.